CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
3.900
+0.150 (4.00%)
Oct 27, 2026, 4:00 PM EDT - Market closed

CollPlant Biotechnologies Revenue

CollPlant Biotechnologies had revenue of $108.00K in the quarter ending June 30, 2026, a decrease of -39.66%. This brings the company's total for the last twelve months to $318.00K, down -86.76% year-over-year. In the year 2025, CollPlant Biotechnologies had annual revenue of $2.37M with 360.39% growth. That makes CollPlant Biotechnologies the 45,038th largest company in the world by revenue and 6,479th in the United States.

Revenue (ttm)
$318.00K
Revenue Growth
-86.76%
P/S Ratio
22.83
Revenue / Employee
$8,154
Employees
39
Market Cap
7.37M

Revenue Chart

Revenue by Geography

  • United States 2.18M 91.8%
  • Europe and Other 98.00K 4.1%
  • Canada 96.00K 4.0%
  • Israel 1.00K 0.0%

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.37M1.86M360.39%
Dec 31, 2024515.00K-10.44M-95.30%
Dec 31, 202310.96M10.66M3,565.22%
Dec 31, 2022299.00K-15.34M-98.09%
Dec 31, 202115.64M9.50M154.86%
Dec 31, 20206.14M3.82M164.75%
Dec 31, 20192.32M-2.70M-53.77%
Dec 31, 20185.01M4.55M982.94%
Dec 31, 2017463.00K387.12K510.15%
Dec 31, 201675.88K--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.